Atrial fibrillation: Difference between revisions
No edit summary |
No edit summary |
||
(3 intermediate revisions by 2 users not shown) | |||
Line 16: | Line 16: | ||
{{Atrial fibrillation}} | {{Atrial fibrillation}} | ||
{{Patient}} | {{Patient}} | ||
{{CMG}} | {{CMG}} {{AE}} {{Anahita}} {{Laith}} | ||
{{SK}} AF; afib; lone fibrillator | {{SK}} AF; afib; lone fibrillator | ||
==[[Atrial fibrillation overview|Overview]]== | ==[[Atrial fibrillation overview|Overview]]== | ||
==Atrial fibrillation historical perspective== | ==[[Atrial fibrillation historical perspective|Historical Perspective]]== | ||
==[[Atrial fibrillation classification|Classification]]== | ==[[Atrial fibrillation classification|Classification]]== |
Revision as of 03:26, 14 December 2022
Resident Survival Guide |
Sinus rhythm |
Atrial fibrillation |
Atrial Fibrillation Microchapters | |
Special Groups | |
---|---|
Diagnosis | |
Treatment | |
Cardioversion | |
Anticoagulation | |
Surgery | |
Case Studies | |
Atrial fibrillation On the Web | |
For patient information, click here. Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Anahita Deylamsalehi, M.D.[2] Laith Adnan Allaham, M.D.[3]
Synonyms and keywords: AF; afib; lone fibrillator
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Atrial Fibrillation from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Special Groups
Postoperative AF | Acute Myocardial Infarction | Wolff-Parkinson-White Preexcitation Syndromes | Hypertrophic Cardiomyopathy | Hyperthyroidism | Pulmonary Diseases | Pregnancy | Patients Presenting with ACS and/or PCI or Valve Intervention
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | EKG Examples | Afib with LBBB EKG Examples | Chest X Ray | Echocardiography | Holter Monitoring and Exercise Stress Testing | Cardiac MRI
Treatment
Rate and Rhythm Control
Rate Control | Maintenance of Sinus Rhythm
Cardioversion
Overview | Electrical Cardioversion | Pharmacological Cardioversion
Anticoagulation
Overview | Warfarin | Converting from or to Warfarin | Converting from or to Parenteral Anticoagulants | Dabigatran
Dabigatran
Dosing | Discontinuation for Surgery and Interventions | Warnings and Precautions | Adverse Reactions | Use in Specific Populations Such as Pregnancy | Overdosage | Clinical Pharmacology | FDA Review of the RE-LY Data | A comparison of the RE-LY and Rocket AF Trials | Estimates of Cost Per Year of Life Saved for Dabigatran
Ablation
Catheter Ablation | AV Nodal Ablation | Surgical Ablation